Seminar: PD-1 in cancer, implications for immunotherapy
PD-1 is a central placed co-stimulatory factor that plays an important role in keeping our immunological tolerance.
Recently anti-PD-1 and anti-PD-L1 antibodies have shown to be extremely potent treatments for various cancers.
MSD Denmark and Merck Research labs, Palo Alto, will host a seminar on the PD-1 axis.
The talks will be given by Elaine Pinheiro, from Merck Research labs, Boston and Jennifer H. Yearley, both from Merck Research labs, Palo Alto. They have both played a central role in the development of anti-PD-1 treatment for Merck/MSD.
Sandwiches will be provided by MSD Denmark during the seminar.
A detailed program will follow.